06/22/22 7:00 AMNasdaq : ACONW, ACON conferencesclinical triallow floatAclarion to Present 2-year Follow Up Data on Pivotal Clinical Trial Linking Nociscan to Better Surgical Outcomes for Discogenic Low Back PainAclarion, Inc. ("Aclarion" or the "Company")RHEA-AIpositive
04/26/22 9:15 PMNasdaq : ACON, ACONW IPOofferinglow floatAclarion, Inc. Announces Closing of $9.4 Million Initial Public OfferingAclarion, Inc. ("Aclarion" or the "Company") (NASDAQ:ACON) (NASDAQ:ACONW), a healthcare technology company that leverages Magnetic Resonance Spectroscopy ("MRS"), artificial intelligence and a proprietary biomarker to optimize clinical treatments forRHEA-AIneutral
04/21/22 7:45 PMNasdaq : ACON, ACONW IPOofferinglow floatAclarion, Inc. Announces Listing on Nasdaq and Pricing of $9.4 Million Initial Public OfferingAclarion, Inc. ("Aclarion" or the "Company") (NASDAQ:ACON)(NASDAQ:ACONW), a healthcare technology company that leverages Magnetic Resonance Spectroscopy ("MRS"), artificial intelligence and a proprietary biomarker to optimize clinical treatments for lowRHEA-AIneutral
